Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide.

scientific article published in February 1998

Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1023/A:1011918719017
P698PubMed publication ID9523312

P2093author name stringH A Havel
S R Myers
A H Pekar
D K Clodfelter
D M Rebhun
K A Destrampe
M L Brader
P2860cites workInfrared Spectroscopic Studies of Lyophilization‐ and Temperature‐Induced Protein AggregationQ30417494
Protein lipidation in cell signalingQ34308460
Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complexQ36279601
Fatty acylated proteins as components of intracellular signaling pathwaysQ37927014
Monomeric insulins and their experimental and clinical implicationsQ37977223
Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: in vitro evaluationQ38573870
Solid-phase aggregation of proteins under pharmaceutically relevant conditionsQ40613130
Therapeutic potential of glucagon-like peptide 1 in type 2 diabetesQ40928196
Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-CQ42160638
Protein structures in SDS micelle-protein complexesQ42581377
Interaction of apocytochrome c and derived polypeptide fragments with sodium dodecyl sulfate micelles monitored by photochemically induced dynamic nuclear polarization proton NMR and fluorescence spectroscopyQ45273351
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitusQ45306841
N-myristylation of the catalytic subunit of cAMP-dependent protein kinase conveys structural stability.Q45985547
Estimation of globular protein secondary structure from circular dichroism.Q51259487
Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDMQ58449150
Monomeric insulins obtained by protein engineering and their medical implicationsQ59060531
Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centersQ69357373
Precipitation of insulinotropin in the presence of protamine: effect of phenol and zinc on the isophane ratio and the insulinotropin concentration in the supernatantQ70922414
Stability and stabilization of insulinotropin in a dextran formulationQ70950985
Conformations of peptides corresponding to fatty acylation sites in proteins. A circular dichroism studyQ71977417
Effects of depalmitoylation on physicochemical properties of rhodopsinQ72248586
Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholine micelle as determined by 2D NMRQ72326552
Aggregation pathway of recombinant human keratinocyte growth factor and its stabilizationQ72579183
P433issue2
P304page(s)254-262
P577publication date1998-02-01
P1433published inPharmaceutical ResearchQ7180737
P1476titleEffects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide.
P478volume15

Reverse relations

cites work (P2860)
Q37116075A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.
Q38337206Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
Q100295181Antimicrobial excipient-induced reversible association of therapeutic peptides in parenteral formulations
Q92765348Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1
Q47245423Comparison of free solution capillary electrophoresis and size exclusion chromatography for quantitating non-covalent aggregation of an acylated peptide
Q42826655Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils
Q42083252Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering
Q59062376Physicochemical Analysis and Molecular Modeling of the Fosinoprilβ-Cyclodextrin Inclusion Complex
Q64118590The Discovery and Development of Liraglutide and Semaglutide
Q91889009The Glucagon-Like Peptide 2 Analog Teduglutide Reversibly Associates to Form Pentamers
Q43830570Vaccination with human papillomavirus type 16-derived peptides using a tattoo device.

Search more.